Erik Lindström

1.6k total citations
63 papers, 1.2k citations indexed

About

Erik Lindström is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Erik Lindström has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 17 papers in Oncology. Recurrent topics in Erik Lindström's work include Neuropeptides and Animal Physiology (17 papers), Drug Transport and Resistance Mechanisms (14 papers) and Gastrointestinal motility and disorders (13 papers). Erik Lindström is often cited by papers focused on Neuropeptides and Animal Physiology (17 papers), Drug Transport and Resistance Mechanisms (14 papers) and Gastrointestinal motility and disorders (13 papers). Erik Lindström collaborates with scholars based in Sweden, United Kingdom and United States. Erik Lindström's co-authors include Vicente Martı́nez, R. Håkanson, Mikael Brusberg, Håkan Larsson, Per Norlén, Bengt von Mentzer, Urszula Grabowska, Kjell Andersson, Duan Chen and Ingela Ahlstedt and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Erik Lindström

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Lindström Sweden 22 349 322 251 237 215 63 1.2k
Raquel Guerrero‐Alba Mexico 12 203 0.6× 173 0.5× 140 0.6× 151 0.6× 178 0.8× 29 869
TinaMarie Lieu Australia 15 422 1.2× 269 0.8× 332 1.3× 81 0.3× 190 0.9× 17 1.3k
Dane D. Jensen United States 19 573 1.6× 260 0.8× 374 1.5× 101 0.4× 162 0.8× 36 1.3k
László Kereskai Hungary 17 288 0.8× 300 0.9× 290 1.2× 36 0.2× 182 0.8× 73 1.2k
Danuta H. Malinowska United States 26 988 2.8× 198 0.6× 249 1.0× 245 1.0× 297 1.4× 57 1.8k
Roy B. Dyer United States 21 823 2.4× 239 0.7× 316 1.3× 389 1.6× 346 1.6× 46 1.7k
Mine Kinoshita Japan 18 282 0.8× 134 0.4× 92 0.4× 61 0.3× 141 0.7× 35 769
Nitin Agarwal Germany 20 555 1.6× 352 1.1× 282 1.1× 19 0.1× 124 0.6× 54 1.5k
W. Y. Chey United States 27 316 0.9× 298 0.9× 757 3.0× 438 1.8× 763 3.5× 77 1.9k
Graeme L. Fraser United States 22 490 1.4× 223 0.7× 223 0.9× 51 0.2× 206 1.0× 37 1.6k

Countries citing papers authored by Erik Lindström

Since Specialization
Citations

This map shows the geographic impact of Erik Lindström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Lindström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Lindström more than expected).

Fields of papers citing papers by Erik Lindström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Lindström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Lindström. The network helps show where Erik Lindström may publish in the future.

Co-authorship network of co-authors of Erik Lindström

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Lindström. A scholar is included among the top collaborators of Erik Lindström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Lindström. Erik Lindström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ghallab, Ahmed, Mattias Mandorfer, Guido Stirnimann, et al.. (2025). Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors. Journal of Hepatology. 83(5). 1204–1217. 3 indexed citations
3.
Lindström, Erik, et al.. (2025). Lipocalin 2 in Obesity and Diabetes: Insights into Its Role in Energy Metabolism. Endocrines. 6(1). 4–4. 1 indexed citations
4.
Kuipers, Folkert, et al.. (2023). Odevixibat Treatment Induces Biliary Bile Acid Secretion in Responsive Patients With Bile Salt Export Pump Deficiency. Gastroenterology. 165(2). 496–498.e1. 6 indexed citations
5.
6.
Montague-Cardoso, Karli, et al.. (2019). Changes in vascular permeability in the spinal cord contribute to chemotherapy-induced neuropathic pain. Brain Behavior and Immunity. 83. 248–259. 26 indexed citations
7.
Lindström, Erik, Ian Henderson, Ylva Terelius, et al.. (2018). Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711. Journal of Translational Medicine. 16(1). 125–125. 37 indexed citations
8.
Nissen, Thomas, Christina Brock, Jens Lykkesfeldt, Erik Lindström, & Leif Hultin. (2018). Pharmacological modulation of colorectal distension evoked potentials in conscious rats. Neuropharmacology. 140. 193–200. 4 indexed citations
9.
Burston, James J., Luting Xu, Urszula Grabowska, et al.. (2016). The Cathepsin K inhibitor L-006235 has analgesic and disease modifying properties in the MIA model of osteoarthritis. Osteoarthritis and Cartilage. 24. S454–S454. 2 indexed citations
10.
Lindström, Erik, Urszula Grabowska, Markus Jerling, & Charlotte Edenius. (2014). MIV-711, a highly selective cathepsin K inhibitor, reduces biomarkers of bone resorption and cartilage degradation in healthy subjects. Osteoarthritis and Cartilage. 22. S197–S197. 4 indexed citations
11.
Gossas, Thomas, Lotta Vrang, Ian Henderson, et al.. (2011). Aliskiren displays long-lasting interactions with human renin. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(2). 219–224. 5 indexed citations
12.
Fuller, K., Erik Lindström, Michael Edlund, et al.. (2010). The resorptive apparatus of osteoclasts supports lysosomotropism and increases potency of basic versus non-basic inhibitors of cathepsin K. Bone. 46(5). 1400–1407. 7 indexed citations
13.
Christopeit, Tony, M. Carmen Villaverde, Thomas Gossas, et al.. (2010). Effect of the Protonation State of the Titratable Residues on the Inhibitor Affinity to BACE-1. Biochemistry. 49(34). 7255–7263. 47 indexed citations
14.
Ahlstedt, Ingela, John W. Smith, Chris Perrey, et al.. (2008). Occurrence and pharmacological characterization of four human tachykinin NK2 receptor variants. Biochemical Pharmacology. 76(4). 476–481. 4 indexed citations
15.
Mentzer, Bengt von, et al.. (2006). Functional CRF receptors in BON cells stimulate serotonin release. Biochemical Pharmacology. 73(6). 805–813. 22 indexed citations
16.
Larsson, Marie, et al.. (2006). Assessment of Visceral Pain-Related Pseudo-Affective Responses to Colorectal Distension in Mice by Intracolonic Manometric Recordings. Journal of Pain. 7(2). 108–118. 37 indexed citations
17.
Ahlstedt, Ingela, Erik Lindström, Arne Svensson, et al.. (2006). Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors. Biochemical Pharmacology. 73(2). 259–269. 15 indexed citations
18.
Lindström, Erik, Per Norlén, & Rolf Håkanson. (2000). Histamine depletion does not affect pancreastatin secretion from isolated rat stomach ECL cells. European Journal of Pharmacology. 387(1). 19–25. 5 indexed citations
19.
Lindström, Erik, Maria Björkqvist, & R. Håkanson. (1999). Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells. British Journal of Pharmacology. 127(2). 530–536. 37 indexed citations
20.
Lindström, Erik, et al.. (1997). Evaluation of Three Novel Cholecystokinin‐B/Gastrin Receptor Antagonists: A Study of their Effects on Rat Stomach Enterochromaffin‐Like Cell Activity. Pharmacology & Toxicology. 81(5). 232–237. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raquel Guerrero‐Alba Breakdown of academic impact, for papers by TinaMarie Lieu Breakdown of academic impact, for papers by Dane D. Jensen Breakdown of academic impact, for papers by László Kereskai Breakdown of academic impact, for papers by Danuta H. Malinowska Breakdown of academic impact, for papers by Roy B. Dyer Breakdown of academic impact, for papers by Mine Kinoshita Breakdown of academic impact, for papers by Nitin Agarwal Breakdown of academic impact, for papers by W. Y. Chey Breakdown of academic impact, for papers by Graeme L. Fraser
Rankless by CCL
2026